Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,694 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06478589RecruitingPhase 2
Survivorship care priorities for older breast cancer survivors
This study looks at what matters most to older breast cancer survivors who have finished treatment. It helps doctors design care plans that fit your personal priorities and health needs.
Bellaire, TexasAges 65–100 - NCT06411041Enrolling by invitation
Pelvic floor training plus yoga for breast cancer survivors
This study looks at whether a program that combines pelvic floor exercises (like Kegels) with yoga can improve bladder and pelvic health in women who have had breast cancer. It may help with symptoms like leaking urine, pressure, or discomfort.
TaipeiAges 20–60 - NCT06450873RecruitingPhase 2
Turkey tail mushroom before breast cancer surgery
This trial tests whether taking a turkey tail mushroom supplement before breast cancer surgery can help the immune system fight the cancer. It is for post-menopausal women with a common type of breast cancer (ER-positive, HER2-negative) that is growing at a moderate or faster rate (Ki-67 score of 10% or more).
Scottsdale, ArizonaAges 18 years+ - NCT06150326Recruiting
Medical honey for wound treatment in intensive care
This trial tests whether medical honey can help heal wounds like bedsores, cuts, or surgical openings in intensive care patients. If you have a fresh wound that meets the size requirements, you may be able to join.
AngersAges 18 years+ - NCT06264817Recruiting
Adjustable sleeve for arm swelling after breast cancer
This trial tests a new adjustable compression sleeve for arm swelling (lymphedema) after breast cancer. It aims to see if the sleeve is comfortable and effective at reducing swelling.
AnkaraAges 18 years+ - NCT06311266Recruiting
Robot-assisted brain surgery study
This study tests whether a robot can help surgeons perform precise endoscopic procedures in the brain or pituitary area. It may be an option for people who need a ventriculostomy or surgery for a pituitary growth.
Graz, StyriaAges 18–80 - NCT06226844Recruiting
Can a vibration device help people with leg artery disease walk further?
This study tests a device called BeatMove to see if it can improve walking distance for people with blocked leg arteries that cause pain when walking. It may help if you have this condition and already take medicines for it.
NîmesAges 18 years+ - NCT06271057RecruitingPhase 2
Golcadomide after CAR T-cell for high-risk large B-cell lymphoma
This trial tests a new drug, golcadomide, given after CAR T-cell therapy to prevent relapse in people with aggressive large B-cell lymphoma who are at high risk. If you've had or are about to receive CAR T-cells, this study may help keep your lymphoma in remission.
CréteilAges 18 years+ - NCT06260514RecruitingPhase 1
New drug APR-1051 for advanced solid tumors
This trial tests a new drug called APR-1051 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this drug is safe and effective.
Houston, TexasAges 18 years+ - NCT06327685RecruitingPhase 1
Avapritinib and Decitabine for SM-AHN
This trial tests a combination of two drugs, avapritinib and decitabine, for people with systemic mastocytosis plus another blood cancer (SM-AHN). The goal is to see if the combination works better than either drug alone.
Phoenix, ArizonaAges 18 years+ - NCT06306118Recruiting
Guiding device for more precise brain biopsies
This trial tests a new positioning device that helps doctors take small tissue samples (biopsies) from brain lesions more precisely during surgery. If you have a brain lesion that needs to be removed, this study may help improve accuracy.
Graz, StyriaAges 18–80 - NCT06330012Recruiting
Understanding resistance to T-Dxd in HER2+ breast cancer
This study looks at why some HER2-positive breast cancer patients stop responding to the drug T-Dxd (trastuzumab deruxtecan). It aims to find out how resistance develops, which may help improve future treatments.
SeoulAges Any age - NCT05963490RecruitingPhase 2
Regorafenib with or without targeted immunotherapy and radiation for spread colon cancer
This Phase 2 study tests whether taking regorafenib alone or with immunotherapy (toripalimab) and a lower-dose radiation plan can better control metastatic colon or rectal cancer that has MSS/pMMR. It may help by combining cancer-blocking medicine with immune activation and focused radiation to metastatic spots.
ShanghaiAges 18–70 - NCT06030804Recruiting
Dexmedetomidine during surgery and long-term survival
This trial studies whether adding a medication called dexmedetomidine during cancer surgery can improve long-term survival. It is for older adults having major cancer surgery that lasts at least two hours and who will need a pain pump after the operation.
Hefei, AnhuiAges 60 years+ - NCT06028022RecruitingPhase 2
Reishi mushroom for fatigue and joint/muscle pain in breast cancer
This trial tests whether a reishi mushroom extract can help reduce fatigue and joint or muscle pain in people with breast cancer who are taking aromatase inhibitors. If you have these symptoms, you may be able to join.
Albert Lea, MinnesotaAges 18 years+ - NCT06176534RecruitingPhase 2
Comparing two treatments for advanced breast cancer with low hormone receptor
This trial compares two treatment options for advanced breast cancer that has low hormone receptor levels and is HER2-negative. It tests whether a combination of chemotherapy followed by maintenance therapy works better than a CDK4/6 inhibitor combined with hormone therapy. This is for people who have not had chemotherapy for their advanced disease.
Zhengzhou, HenanAges 18 years+ - NCT06037421Recruiting
Bacteria in breast milk of NICU mothers
This study looks at the bacteria naturally found in breast milk. Researchers want to learn more about the germs in milk from mothers whose babies are in the neonatal intensive care unit.
Corbeil-Essonnes, FranceAges 1 hour+ - NCT06061978Recruiting
Pacing after a heart procedure for rapid atrial fibrillation
This trial studies whether a special type of pacing (stimulating the heart's natural electrical system) works better than standard pacing after a procedure to control very fast heart rhythms. It's for people who already have a pacemaker and are getting a specific treatment for atrial fibrillation.
CaenAges 18 years+ - NCT05945199Recruiting
Brain stimulation to reduce cravings in chemsex users
This trial tests a non-painful brain stimulation method (tDCS) to help reduce cravings related to chemsex. If you qualify, you’ll be randomly assigned to real stimulation or a sham (placebo) and complete study visits and questionnaires.
DijonAges 18 years+ - NCT06020625Recruiting
Genetic testing for advanced cancers
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
RomeAges 18 years+ - NCT05940233Recruiting
See if letrozole plus misoprostol works better than misoprostol alone
This study compares two medicines to help end an early pregnancy loss: letrozole plus misoprostol versus misoprostol by itself. It looks at whether more people have a complete abortion and may help improve how quickly and completely the pregnancy tissue leaves.
Bangkok, YannawaAges Any age - NCT06051214Recruiting
Predicting blood clots in cancer patients at risk
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
Saint-HerblainAges 18 years+ - NCT06006273RecruitingPhase 1
Testing a new drug combo for children with returning solid tumors
This trial tests a new combination of three chemotherapy drugs (eribulin, irinotecan, and temozolomide) for children and young adults whose solid tumors have come back or not responded to standard treatment. The goal is to see if this combination is safe and effective.
Houston, TexasAges 1–25 - NCT06034821Enrolling by invitationPhase 4
ECT vs. ketamine for suicidal depression in adults
This trial compares two treatments—ECT (electroconvulsive therapy, which uses electrical stimulation) and ketamine (a medicine given as a shot)—to see which works better for quickly reducing suicidal depression. It is for adults who are in a severe depressive episode with active suicidal thoughts.
San Francisco, CaliforniaAges 18–90
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,694 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.